PS
Peter Soparkar
Chief Operating Officer

Peter Soparkar insider trades: Adverum Biotechnologies (ADVM) stock buys and sales

Chief Operating Officer, Adverum Biotechnologies Last trade Dec 5, 2025 20 Form 4 filings
$0
Sold, last 12 months
0 sales
$211K
Bought, last 12 months
1 buy
7
Open-market trades
since 2020
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Peter reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 5, 2025ADVM↑ Buy$211K
May 15, 2025ADVM↓ Sell$6K
Mar 15, 2023ADVM↓ Sell$10K
Sep 19, 2022ADVM↓ Sell$14K
Apr 19, 2022ADVM↑ Buy$25K
Dec 8, 2021ADVM↑ Buy$48K
Aug 17, 2020ADVM↑ Buy$100K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ADVM insiders

Open-market trades in the last 12 months

About Peter Soparkar's insider trades

Peter Soparkar is Chief Operating Officer at Adverum Biotechnologies (ADVM). Since Aug 17, 2020, Peter has reported 4 open-market purchases worth $384K and 3 sales worth $31K on SEC Form 4. In the last 12 months: 1 buy ($211K).

Their filings also include grants and awards (13 filings), shares returned to the company (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADVM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.